Search Within

Computational Oncology Service

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (261)
  2. Meeting Abstract (196)
  3. Editorial (9)
  4. Research Letter (2)
  5. Review (2)
  6. Conference Paper (1)
Groups
  1. Department of Medicine (471)
  2. Epidemiology and Biostatistics (471)
  3. Solid Tumor Oncology Division (471)
  4. GSK Faculty (463)
  5. Human Oncology and Pathogenesis Program (411)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (352)

More Groups

People
  1. Nikolaus Schultz (324)
  2. David Solit (165)
  3. Michael Berger (164)
  4. Marc Ladanyi (81)
  5. Walid Chatila (81)
  6. Francisco Sanchez Vega (79)

More People

Years
  1. 2025 (22)
  2. 2024 (47)
  3. 2023 (48)
  4. 2022 (82)
  5. 2021 (41)
  6. 2020 (54)

More Years

Publications
  1. Journal of Clinical Oncology (105)
  2. Cancer Research (48)
  3. Clinical Cancer Research (41)
  4. Cancer Discovery (17)
  5. Nature (17)
  6. Blood (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (119)
  2. American Association for Cancer Research (115)
  3. Nature Publishing Group (53)
  4. Elsevier Inc. (25)
  5. Oxford University Press (25)
  6. Cell Press (21)

More Publishers

Results (471)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Germline contributions to clonal hematopoiesis in solid cancer patients
    Meeting Abstract

    Franch-Expósito, S.; Srinivasan, P.; Ptashkin, R.; Bandlamudi, C.; Bolton, K. L.; Gedvilaite, E.; Menghrajani, K.; Mandelker, D.; Comen, E.; Norton, L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S.; Zhang, H.; Nissan, M.; Kundra, R.; Su, J.; LaFave, L.; Gala, K.; Vanderbilt, C.; Arcila, M.; Ladanyi, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis
    Journal Article

    Yaeger, R.; Paroder, V.; Bates, D. D. B.; Capanu, M.; Chou, J.; Tang, L.; Chatila, W.; Schultz, N.; Hersch, J.; Kelsen, D.
    Clinical Colorectal Cancer (2020)

    Fulltext@MSK | Save
  • Mathematical modeling of tumor heterogeneity to optimize treatment scheduling and delay the evolution of resistance
    Meeting Abstract

    Mathur, D.; Taylor, B. P.; Chatila, W.; Schultz, N.; Razavi, P.; Xavier, J.
    Cancer Research (2020)

    Fulltext@MSK | Save